- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +19 more
- Locations
-
- GSK Investigational Site Overland Park, Kansas, United States
Clinical trial condition
Lipodystrophy
Explore clinical trials studying Lipodystrophy. Study availability and eligibility vary by location and protocol.
26 public trials
5 recruiting studies
Lipodystrophy trial results
NCT00383734
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +19 more
- Locations
-
- Hôpital Saint-Louis Service des Maladies Infectieuses Paris, France
Completed
Psychological Morbidity and Facial Volume in HIV Lipodystrophy: Quantification of Treatment Outcome
NCT01359917
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +19 more
- Locations
-
Not specified
NCT00135356
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +19 more
- Locations
-
- Local Institution Fort Lauderdale, Florida, United States
- Local Institution Honolulu, Hawaii, United States
- Local Institution Huntersville, North Carolina, United States
- Local Institution Houston, Texas, United States
NCT01077765
- Conditions
- Antiretroviral Side Effects, Blood-Borne Infections, Communicable Diseases, +22 more
- Locations
-
- Hopital europeen Georges Pompidou Paris, France
Active, Not Recruiting
A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD)
NCT06548100
- Conditions
- Body Weight, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Diabetes Mellitus, +28 more
- Locations
-
- National Institutes of Health Bethesda, Maryland, United States
- University of Michigan Ann Arbor, Michigan, United States